Inotiv, Inc. (NASDAQ:NOTV – Get Free Report) COO John Gregory Beattie bought 30,000 shares of the stock in a transaction on Tuesday, December 10th. The stock was acquired at an average price of $4.75 per share, with a total value of $142,500.00. Following the completion of the acquisition, the chief operating officer now owns 161,761 shares of the company’s stock, valued at $768,364.75. This represents a 22.77 % increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.
Inotiv Price Performance
Shares of NASDAQ NOTV opened at $5.95 on Friday. The firm has a market capitalization of $154.79 million, a P/E ratio of -1.42 and a beta of 3.62. The firm’s 50-day moving average price is $2.78 and its 200-day moving average price is $2.09. The company has a current ratio of 1.37, a quick ratio of 1.22 and a debt-to-equity ratio of 2.29. Inotiv, Inc. has a 1-year low of $1.23 and a 1-year high of $11.42.
Institutional Trading of Inotiv
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Vanguard Group Inc. boosted its holdings in Inotiv by 1.0% in the first quarter. Vanguard Group Inc. now owns 1,043,460 shares of the company’s stock worth $11,415,000 after acquiring an additional 10,146 shares in the last quarter. KPP Advisory Services LLC raised its position in shares of Inotiv by 4.5% during the second quarter. KPP Advisory Services LLC now owns 238,138 shares of the company’s stock worth $395,000 after purchasing an additional 10,347 shares during the period. Geode Capital Management LLC lifted its holdings in shares of Inotiv by 7.7% in the 3rd quarter. Geode Capital Management LLC now owns 250,895 shares of the company’s stock worth $427,000 after purchasing an additional 18,039 shares in the last quarter. Renaissance Technologies LLC grew its position in Inotiv by 29.9% in the 2nd quarter. Renaissance Technologies LLC now owns 164,164 shares of the company’s stock valued at $273,000 after purchasing an additional 37,800 shares during the period. Finally, King Luther Capital Management Corp increased its stake in Inotiv by 101.4% during the 2nd quarter. King Luther Capital Management Corp now owns 198,600 shares of the company’s stock valued at $330,000 after purchasing an additional 100,000 shares in the last quarter. 18.17% of the stock is owned by institutional investors.
Analysts Set New Price Targets
Check Out Our Latest Stock Report on NOTV
About Inotiv
Inotiv, Inc provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries. It operates through two segment: Discovery and Safety Assessment (DSA), and Research Models and Services (RMS). The DMS segment manufactured scientific instruments for life sciences research and the related software for use by pharmaceutical companies, universities, government research centers, and medical research institutions under the Company's BASi product line.
Featured Articles
- Five stocks we like better than Inotiv
- Want to Profit on the Downtrend? Downtrends, Explained.
- FinWise Bancorp’s CEO Talks Strategy Behind Fintech Success
- Health Care Stocks Explained: Why You Might Want to Invest
- Broadcom: Turning the Mag 7 Into 8 Trillion-Dollar Tech Giants
- What is the Nikkei 225 index?
- SoundHound AI: Can Its Meteoric Rise Sustain Into 2025?
Receive News & Ratings for Inotiv Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inotiv and related companies with MarketBeat.com's FREE daily email newsletter.